Table 2.
Variable | Toxicity G3–4 | Early Death | Unplanned Hospitalizations | ||||||
---|---|---|---|---|---|---|---|---|---|
No | Yes | p Value | No | Yes | p Value | No | Yes | p Value | |
ECOG PS | 0.95 | 0.91 | 0.031 | ||||||
2 | 9 | 4 | 10 | 3 | 6 | 7 | |||
0–1 | 133 | 69 | 158 | 44 | 149 | 53 | |||
IADL | 0.04 | 9672 | 0.20 | 0.0001 | |||||
≤7 | 85 | 33 | 22 | 98 | 20 | ||||
8 | 57 | 40 | 25 | 57 | 40 | ||||
ADL | 0.85 | 0.038 | 0.004 | ||||||
≤5 | 22 | 12 | 22 | 12 | 16 | 18 | |||
6 | 120 | 61 | 146 | 35 | 139 | 42 | |||
Charlson comorbidity score | 0.56 | 0.008 | 0.015 | ||||||
≥2 | 45 | 26 | 48 | 23 | 58 | 12 | |||
0–1 | 97 | 47 | 120 | 26 | 96 | 482 | |||
Unintentional weight loss % | 0.012 | 0.000 | 0.0001 | ||||||
>5% | 40 | 33 | 40 | 33 | 37 | 36 | |||
≤5% | 102 | 40 | 128 | 14 | 118 | 24 | |||
Creatinine Clearance mL/min | 0.022 | 0.26 | 0.0001 | ||||||
<50 | 42 | 33 | 60 | 21 | 36 | 46 | |||
≥50 | 100 | 40 | 108 | 26 | 119 | 14 | |||
Albumin g/dL | 0.17 | 0.000 | 0.51 | ||||||
≤35 | 24 | 18 | 23 | 19 | 32 | 10 | |||
>35 | 118 | 55 | 145 | 28 | 123 | 50 | |||
Hemoglobin (g/dL) | 0.61 | 0.02 | 0.48 | ||||||
<11 | 27 | 16 | 28 | 15 | 32 | 15 | |||
≥11 | 1157 | 57 | 140 | 32 | 123 | 45 | |||
Metastatic status | 0.49 | 0.000 | 0.000 | ||||||
M1 | 67 | 38 | 69 | 36 | 64 | 41 | |||
M0 | 75 | 35 | 99 | 11 | 91 | 19 | |||
Chemotherapy | 0.37 | 0.96 | 0.37 | ||||||
Standard therapy | 63 | 37 | 78 | 22 | 75 | 25 | |||
Reduced/monotherapy | 79 | 36 | 90 | 25 | 80 | 35 | |||
MAX2 index | 0.03 | 0.73 | 0.84 | ||||||
≥0.45 | 87 | 55 | 110 | 32 | 103 | 39 | |||
0–0.44 | 55 | 18 | 58 | 15 | 52 | 21 |
Abbreviations: ECOG PS: Eastern Cooperative Oncology Group performance status, ADL: Activity of Daily Living, IADL: Instrumental activity of Daily Living.